Silicones in dermatological topical drug formulation: Overview and advances

Int J Pharm. 2022 Sep 25:625:122111. doi: 10.1016/j.ijpharm.2022.122111. Epub 2022 Aug 13.

Abstract

Silicones, more specifically those of the polydimethylsiloxane type, have been widely used in the pharmaceutical industry for decades, particularly in topical applications. In the dermatological field, in addition to provide undeniable textural and sensory benefits, they can play important functions in the physicochemical properties, stability and biopharmaceutical behavior of these formulations. However, despite the notable advances that can be attributed to the family of silicones, the reputation of these compounds is quite bad. Indeed, silicones, even if they derive from sand, are synthetic compounds. Moreover, they are not biodegradable. They flow into our wastewater and oceans, accumulating in the fauna and flora. This obviously raises many concerns in the common imagination. Do silicones represent a danger for our environment? Should the human species worry about long term toxic effects? Are the claimed benefits really that important? After exploring the various applications of silicone excipients in topical dermatological formulations with a special focus on recent advances which open breathtaking prospects for dermatological applications, this paper shed light on the specific challenges involved in preparation of silicone-based drug as well as, the in vivo behavior of these polymers, the toxicological and environmental risks associated with their application.

Keywords: Pharmaceutics; Silicones; Skin; Topical administration.

Publication types

  • Review

MeSH terms

  • Chemistry, Pharmaceutical*
  • Drug Carriers / chemistry
  • Drug Compounding
  • Excipients / chemistry
  • Humans
  • Silicones* / chemistry

Substances

  • Drug Carriers
  • Excipients
  • Silicones